JP2004506740A5 - - Google Patents

Download PDF

Info

Publication number
JP2004506740A5
JP2004506740A5 JP2002521477A JP2002521477A JP2004506740A5 JP 2004506740 A5 JP2004506740 A5 JP 2004506740A5 JP 2002521477 A JP2002521477 A JP 2002521477A JP 2002521477 A JP2002521477 A JP 2002521477A JP 2004506740 A5 JP2004506740 A5 JP 2004506740A5
Authority
JP
Japan
Prior art keywords
compound
formula
compound according
infectious diseases
hexopyranosyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002521477A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506740A (ja
JP4162992B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/009560 external-priority patent/WO2002016380A1/en
Publication of JP2004506740A publication Critical patent/JP2004506740A/ja
Publication of JP2004506740A5 publication Critical patent/JP2004506740A5/ja
Application granted granted Critical
Publication of JP4162992B2 publication Critical patent/JP4162992B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002521477A 2000-08-22 2001-08-20 抗菌活性を有する新規マクロライド Expired - Fee Related JP4162992B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117971 2000-08-22
PCT/EP2001/009560 WO2002016380A1 (en) 2000-08-22 2001-08-20 New macrolides with antibacterial activity

Publications (3)

Publication Number Publication Date
JP2004506740A JP2004506740A (ja) 2004-03-04
JP2004506740A5 true JP2004506740A5 (US20070167479A1-20070719-C00034.png) 2005-03-17
JP4162992B2 JP4162992B2 (ja) 2008-10-08

Family

ID=8169600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002521477A Expired - Fee Related JP4162992B2 (ja) 2000-08-22 2001-08-20 抗菌活性を有する新規マクロライド

Country Status (14)

Country Link
US (1) US6740642B2 (US20070167479A1-20070719-C00034.png)
EP (1) EP1313751B1 (US20070167479A1-20070719-C00034.png)
JP (1) JP4162992B2 (US20070167479A1-20070719-C00034.png)
KR (1) KR100502031B1 (US20070167479A1-20070719-C00034.png)
CN (1) CN1234718C (US20070167479A1-20070719-C00034.png)
AT (1) ATE408614T1 (US20070167479A1-20070719-C00034.png)
AU (1) AU2001282105A1 (US20070167479A1-20070719-C00034.png)
BR (1) BR0113472A (US20070167479A1-20070719-C00034.png)
CA (1) CA2419296C (US20070167479A1-20070719-C00034.png)
DE (1) DE60135859D1 (US20070167479A1-20070719-C00034.png)
ES (1) ES2313975T3 (US20070167479A1-20070719-C00034.png)
MX (1) MXPA03001607A (US20070167479A1-20070719-C00034.png)
WO (1) WO2002016380A1 (US20070167479A1-20070719-C00034.png)
ZA (1) ZA200301047B (US20070167479A1-20070719-C00034.png)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1727702A (en) * 2000-12-21 2002-07-01 Glaxo Group Ltd Macrolide antibiotics
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
WO2003024986A1 (en) * 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
WO2004108745A2 (en) * 2003-06-05 2004-12-16 Enanta Pharmaceuticals, Inc. 11-12 bicyclic erythromycin derivatives
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
PL1846430T3 (pl) 2005-02-09 2009-08-31 Basilea Pharmaceutica Ag Nowe makrolidy
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
US8278281B2 (en) 2005-08-24 2012-10-02 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
DK2049556T3 (da) 2006-08-09 2013-08-12 Basilea Pharmaceutica Ag Nye makrolider anvendelige mod inflammatoriske og allergiske sygdomme
WO2008023248A2 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
KR101617897B1 (ko) 2008-02-08 2016-05-03 바실리어 파마슈티카 아게 신규 마크로라이드 및 그의 용도
JP5769972B2 (ja) * 2008-02-08 2015-08-26 バジリア ファルマスーチカ アーゲーBasilea Pharmaceutica AG Pde阻害により仲介される疾患を処置するためのマクロライド
BRPI1011959A2 (pt) 2009-05-27 2016-04-26 Wockhardt Research Center compostos de cetolídeo tendo atividade antimicrobiana.
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
PL2673285T3 (pl) 2010-12-09 2017-12-29 Wockhardt Limited Związki ketolidowe
JP5718488B2 (ja) 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
PL2938623T3 (pl) * 2012-12-31 2017-03-31 Basilea Pharmaceutica Ag Wybrane makrolidy o działaniu hamującym pde4
MX2018010652A (es) 2016-01-12 2021-07-16 Wockhardt Ltd Composiciones farmaceuticas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Similar Documents

Publication Publication Date Title
JP2004506740A5 (US20070167479A1-20070719-C00034.png)
CN102504001B (zh) 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
JP2006523216A5 (US20070167479A1-20070719-C00034.png)
JP2005526107A5 (US20070167479A1-20070719-C00034.png)
CN107929743B (zh) 治疗肺部疾病的高穿透力前药组合物和医药组合物
CA2632626A1 (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
JP2003501474A5 (US20070167479A1-20070719-C00034.png)
JP2009517411A5 (US20070167479A1-20070719-C00034.png)
JP2008531604A5 (US20070167479A1-20070719-C00034.png)
JP2010511039A5 (US20070167479A1-20070719-C00034.png)
JP2006182786A5 (US20070167479A1-20070719-C00034.png)
JP2003509349A5 (US20070167479A1-20070719-C00034.png)
US20180221405A1 (en) Silicate containing compositions and methods of treatment
JP2021102643A5 (US20070167479A1-20070719-C00034.png)
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
JP2006503850A5 (US20070167479A1-20070719-C00034.png)
JP2003502367A5 (US20070167479A1-20070719-C00034.png)
JP2001520994A5 (US20070167479A1-20070719-C00034.png)
JP2004531478A5 (US20070167479A1-20070719-C00034.png)
KR20100045513A (ko) 감염의 치료 또는 제어를 위한, 퀴놀론을 포함하는 조성물 및 방법
JP2003520208A5 (US20070167479A1-20070719-C00034.png)
CN101212968B (zh) 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
JP5882296B2 (ja) 創傷の予防及び治療のための組成物及び方法
ES2488821T3 (es) Proceso de preparación de un compuesto antiviral